Daniel L Kisner Zynerba Pharmaceuticals, Inc. (ZYNE) insider trading activity

Daniel L Kisner is of Zynerba Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of ZYNE, which is worth approximately $0. The most recent transaction as insider was on Oct 10, 2023, when has been sold 75,778 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

DANIEL L KISNER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 10 2023	SELL Disposition due to a tender of shares in a change of control transaction	-	75,778 Reduced 100.0%	0 Common Stock
Jun 14 2023	SELL Open market or private sale	$40 $0.35 p/Share	115 Reduced 0.15%	75,778 Common Stock
Jun 13 2023	BUY Grant, award, or other acquisition	-	47,824 Added 38.66%	75,893 Common Stock
Jun 14 2022	SELL Open market or private sale	$40 $1.01 p/Share	40 Reduced 0.14%	28,069 Common Stock
Jun 14 2022	BUY Grant, award, or other acquisition	-	23,109 Added 45.12%	28,109 Common Stock
Aug 03 2021	BUY Grant, award, or other acquisition	-	5,000 Added 50.0%	5,000 Common Stock

Also insider at

HSTO

Histogen Inc. Healthcare

Director

ONCT

Oncternal Therapeutics, Inc. Healthcare

DVAX

DYNAVAX TECHNOLOGIES CORP Healthcare

DLK

Daniel L Kisner

Emeryville, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZYNE shares.

Notify only if

Value

Insider Trading

Get notified when an Zynerba Pharmaceuticals, Inc. insider buys or sells ZYNE shares.

Notify only if

Operation

Value

Type

News

Receive news related to Zynerba Pharmaceuticals, Inc.

Track Activities on ZYNE

Account